Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study

Radiotherapy and Oncology

Volumn 71, Issue 3, 2004, Pages 275-280

  Mohanti, Bidhu K ^a   Umapathy, Hombaiah ^a   Bahadur, Sudhir ^b   Thakar, Alok ^b   Pathy, Sushmita ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Fractionation; Head and neck cancer; Palliation; Radiotherapy; Survival; Symptoms

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ANALGESIA; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; COUGHING; DESQUAMATION; DYSPHAGIA; ERYTHEMA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HOARSENESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUCOSA INFLAMMATION; OTALGIA; PALLIATIVE THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; SURVIVAL ANALYSIS;

EID: 2542448029     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.03.009     Document Type: Article

References (28)

1. Bezjak A., Adam J., Panzarella T., et al. Radiotherapy for brain metastases: defining palliative response. Radiother Oncol. 61:2001;71-76
2. Burns L., Chase D., Goodwin J. Treatment of patients with stage IV cancer: do the ends justify the means? Otolaryngol HN Surg. 97:1987;8-14
3. Campos-Filho N., Franco E.L. Microcomputer-assisted univariate survival data analysis using Kaplan-Meier life table estimators. Comput Methods Programs Biomed. 27:1988;223-228
4. Carvalho A.L., Salvajoli J.V., Kowalski L.P. A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas. Eur Arch Otorhinolaryngol. 257:2000;164-167
5. Chow E., Wu J.S., Hoskin P., Coia L.R., Bentzen S.M., Blitzer P.H. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol. 64:2002;275-280
6. Debrowsky W., Naude J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin c in head and neck cancers. Radiother Oncol. 57:2000;119-124
7. Forbes K. Palliative care in patients with cancer of the head and neck. Clin Otolaryngol. 22:1997;117-122
8. Fu K.K., Clery M., Ang K.K., Byhardt R.W., Maor M.H., Beitler J.J. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Int J Radiat Oncol Biol Phys. 32:1995;589-597
9. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. 2001;IARC Press, Lyon
10. Grau C., Agarwal J.P., Jabeen K., et al. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomized trial. Radiother Oncol. 67:2003;17-26
11. Hall E.J. Radiobiology for the radiologist. 1998;Lippincott, Philadelphia, PA
12. Hall S.F., Boysen M., Groome P.A., Mackillop W. Squamous cell carcinoma of the head and neck in Ontario, Canada, and in southeastern Norway. Laryngoscope. 113:2003;695-701
13. Hayter C.R.R., Hulf-Winters C., Paszat L., et al. A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer. Radiother Oncol. 56:2000;29-333
14. Henk J.M., James K.W. Comparative trial of large and small fractions in the radiotherapy of head and neck cancer. Clin Radiol. 29:1978;611-616
15. Hodson D.I., Bruera E., Eapen L., et al. The role of palliative radiotherapy in advanced head and neck cancer. Can J Oncol. 6:(Suppl 1):1996;54-60
16. Kowalski L.P., Carvalho A.L. Natural history of untreated head and neck cancer. Eur J Cancer. 36:2000;1032-1037
17. Lucente F.E. Treatment of head and neck carcinoma with non-curative intent. Am J Otolaryngol. 15:1994;99-102
18. Maher E.J., Jefferis A.F. Decision making in advanced cancer of the head and neck: variation in the views of medical specialists. J R Soc Med. 83:1990;356-359
19. Medical Research Council - Lung Cancer Working Party. Inoperable non-small cell lung cancer (NSCLC): a Medical Research Council randomized trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer. 63:1991;265-270
20. Mohanti B.K., Bahadur S., Lal P., Gairola M., Rath G.K. Cancers of the head and neck. Rath G.K., Mohanti B.K. Textbook of radiation oncology - principles and practice. 1st ed:2000;131-199 BI Churchill Livingstone, New Delhi
21. Percarpio B., Fischer J.J. Irradiation of advanced head and neck cancer with large daily fractions. Radiology. 121:1976;489-490
22. Pilepich M.V., Munzenrider J.E., Rene J.B. Unorthodox fractionation in the treatment of head and neck tumors. Int J Radiat Oncol Biol Phys. 5:1979;249-252
23. Senn H.J., Glaus A. Supportive care in cancer - 15 years thereafter. Support Care Cancer. 10:2002;8-12
24. Shaw H.J. Palliation in head and neck cancer: discussion paper. J R Soc Med. 79:1986;84-86
25. Tattersall M.H.N., Gattellari M., Voigt K., Butow P.W. When the treatment goal is not cure: are patients informed adequately? Support Care Cancer. 10:2002;314-321
26. Vikram B. Editorial - cancers of the head and neck region in developing countries. Radiother Oncol. 67:2003;1-2
27. Wong R.K.S., Franssen E., Szumacher E., et al. What do patients living with advanced cancer and their carers want to know? - A needs assessment. Support Care Cancer. 10:2002;408-415
28. World Health Organisation. WHO Handbook for reporting results of cancer treatment. Geneva. Offset publication No. 48. 1979